Fully Auto Biochemistry Analyzer Market Size, Share, Growth, and Industry Analysis, By Types (Floor-standing,Bench-top), By Applications (Hospital,Health Center and Clinic,Others) , and Regional Insights and Forecast to 2035

Fully Auto Biochemistry Analyzer Market Overview

Global Fully Auto Biochemistry Analyzer Market size is projected at USD 3372  million in 2026 and is expected to hit USD 4361.4 million by 2035 with a CAGR of 2.9%.

The Fully Auto Biochemistry Analyzer Market Report highlights a rapidly evolving diagnostics landscape driven by automation and high-throughput laboratory demand. Over 70% of modern diagnostic laboratories are integrating fully automated systems to enhance efficiency and accuracy. More than 65% of hospitals globally have adopted automated biochemistry analyzers to reduce manual errors and improve turnaround time. The Fully Auto Biochemistry Analyzer Market Analysis indicates that over 50,000 units are installed annually worldwide, with utilization rates exceeding 80% in large diagnostic centers.

The USA accounts for over 35% of global installations of fully auto biochemistry analyzers, with more than 15,000 diagnostic laboratories operating nationwide. Approximately 75% of hospitals in the USA utilize automated clinical chemistry systems to handle high patient volumes. Over 12 billion laboratory tests are conducted annually in the country, with biochemistry tests representing nearly 60% of diagnostic procedures. Automation penetration exceeds 68% in large hospital networks, while standalone labs report adoption rates above 55%. Increasing chronic disease prevalence, affecting over 130 million individuals, is driving continuous demand for high-capacity analyzers across the USA healthcare system.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: 72% automation adoption, 68% efficiency improvement, 64% error reduction, 70% laboratory preference, 66% workflow optimization
• Major Market Restraint: 48% high equipment cost, 52% maintenance expenses, 46% limited affordability, 49% infrastructure gaps, 44% budget constraints
• Emerging Trends: 61% AI integration, 58% digital diagnostics growth, 63% cloud connectivity adoption, 60% smart lab expansion, 57% remote monitoring usage
• Regional Leadership: 35% North America share, 28% Europe contribution, 30% Asia-Pacific growth dominance, 25% emerging market expansion, 32% developed region usage
• Competitive Landscape: 55% top player dominance, 45% mid-tier competition, 50% innovation-driven strategies, 47% partnerships growth, 52% product differentiation focus
• Market Segmentation: 60% hospital usage, 40% diagnostic labs, 65% high-throughput analyzers, 35% mid-range systems, 58% clinical applications
• Recent Development: 62% product launches increase, 59% R&D investment rise, 54% automation upgrades, 56% technology partnerships, 60% system integration advancements

Fully Auto Biochemistry Analyzer Market Trends

The Fully Auto Biochemistry Analyzer Market Trends indicate a strong shift toward integrated and high-throughput diagnostic systems. Over 67% of laboratories are prioritizing analyzers capable of processing more than 800 tests per hour. Nearly 59% of healthcare facilities are adopting analyzers with advanced software integration, enabling seamless data management and real-time reporting. The Fully Auto Biochemistry Analyzer Market Insights reveal that more than 62% of new installations include features such as automatic calibration, sample tracking, and error detection systems. Additionally, over 55% of laboratories are transitioning to compact, modular analyzers to optimize laboratory space utilization.

The Fully Auto Biochemistry Analyzer Market Outlook also highlights increasing adoption of AI-enabled diagnostics, with more than 60% of manufacturers integrating machine learning algorithms into analyzer systems. Around 58% of laboratories are implementing cloud-based solutions for remote diagnostics and data sharing. The Fully Auto Biochemistry Analyzer Market Opportunities are further driven by rising demand for multi-parameter testing, accounting for over 65% of total diagnostic requirements. Emerging markets are witnessing over 45% increase in analyzer installations due to expanding healthcare infrastructure. These trends are reinforcing the Fully Auto Biochemistry Analyzer Market Growth and shaping future innovation strategies.

Fully Auto Biochemistry Analyzer Market Dynamics

DRIVER

"Increasing Demand for High-Throughput Diagnostics"

The Fully Auto Biochemistry Analyzer Market Growth is primarily driven by the rising demand for high-throughput diagnostic solutions. Over 70% of large laboratories require analyzers capable of handling more than 500 samples per day. Approximately 65% of hospitals report increased patient inflow, necessitating faster diagnostic turnaround times. Automation reduces manual intervention by nearly 68%, significantly improving accuracy and efficiency. Chronic diseases account for over 60% of diagnostic testing volumes, further boosting demand. Additionally, more than 58% of laboratories are investing in advanced analyzers to meet growing test volumes and improve operational productivity.

RESTRAINTS

"High Cost of Equipment and Maintenance"

The Fully Auto Biochemistry Analyzer Market Analysis identifies cost as a major restraint, with over 50% of small laboratories unable to afford advanced systems. Maintenance expenses contribute to nearly 45% of total ownership costs, limiting adoption rates. Around 48% of healthcare facilities face budget constraints that hinder investment in automated analyzers. Furthermore, approximately 42% of laboratories report challenges in upgrading existing infrastructure to support advanced systems. High initial setup costs and ongoing service requirements continue to restrict market penetration, particularly in developing regions.

OPPORTUNITY

"Expansion in Emerging Healthcare Markets"

The Fully Auto Biochemistry Analyzer Market Opportunities are expanding significantly in emerging economies, where healthcare infrastructure is growing rapidly. Over 55% of new laboratory setups in developing regions are adopting automated analyzers. Government healthcare spending has increased by more than 50% in several countries, supporting diagnostic advancements. Approximately 47% of rural healthcare facilities are transitioning to automated systems to improve diagnostic accuracy. Additionally, partnerships between public and private sectors are driving a 52% increase in analyzer deployment, creating substantial growth opportunities for market players.

CHALLENGE

"Technical Complexity and Skilled Workforce Requirement"

The Fully Auto Biochemistry Analyzer Market faces challenges related to technical complexity and the need for skilled professionals. Nearly 49% of laboratories report difficulties in operating advanced analyzer systems due to lack of trained personnel. Around 46% of healthcare facilities face issues with system integration and software management. Training costs account for approximately 40% of operational expenses in automated labs. Additionally, over 44% of laboratories experience downtime due to technical issues, impacting workflow efficiency. Addressing these challenges is critical for sustaining the Fully Auto Biochemistry Analyzer Market Growth and ensuring optimal system utilization.

Fully Auto Biochemistry Analyzer Market Segmentation

The Fully Auto Biochemistry Analyzer Market Segmentation is categorized based on type and application, reflecting diverse operational requirements across laboratories. By type, floor-standing analyzers account for over 60% of installations due to high throughput capacity, while bench-top systems represent nearly 40% driven by compact design and flexibility. By application, hospitals contribute approximately 55% of total demand, followed by health centers and clinics at around 30%, and others including research labs at nearly 15%. The Fully Auto Biochemistry Analyzer Market Analysis highlights increasing demand for customized solutions tailored to testing volumes and facility size.

Download Free Sample to learn more about this report.

BY TYPE

Floor-standing: Floor-standing fully auto biochemistry analyzers dominate the Fully Auto Biochemistry Analyzer Market Share, contributing to more than 60% of global installations due to their ability to process high sample volumes efficiently. These systems are widely used in large hospitals and central diagnostic laboratories where daily sample loads exceed 500 to 2000 tests. Nearly 70% of tertiary care hospitals rely on floor-standing analyzers because they offer continuous operation with minimal downtime, achieving utilization rates above 85%. These analyzers support over 100 parameters simultaneously, making them suitable for multi-test panels including liver, kidney, and metabolic profiles. Approximately 65% of diagnostic chains prefer floor-standing systems due to automation features such as auto-sample loading, barcode scanning, and integrated quality control.

Bench-top: Bench-top fully auto biochemistry analyzers represent approximately 40% of the Fully Auto Biochemistry Analyzer Market Size and are primarily used in small to medium-sized laboratories, clinics, and decentralized healthcare settings. These systems are designed for flexibility and space efficiency, occupying nearly 50% less space compared to floor-standing models. Around 60% of independent diagnostic labs prefer bench-top analyzers due to lower operational complexity and ease of installation. These analyzers typically handle between 100 to 400 tests per day, making them ideal for facilities with moderate sample volumes. Bench-top analyzers offer automation features such as automated reagent dispensing and sample handling, reducing manual workload by nearly 55%. Approximately 58% of clinics report improved turnaround times after adopting these systems, with test results delivered within 30 to 60 minutes for routine panels. 

BY APPLICATION

Hospital: Hospitals account for the largest share of the Fully Auto Biochemistry Analyzer Market Growth, contributing approximately 55% of total demand due to high patient inflow and extensive diagnostic requirements. Large hospitals process more than 1000 samples daily, with biochemistry tests representing nearly 65% of all laboratory investigations. Over 75% of multi-specialty hospitals utilize fully automated analyzers to ensure rapid and accurate diagnostics. These systems are critical for managing chronic diseases, which affect over 60% of hospitalized patients and require frequent biochemical monitoring.

Health Center and Clinic: Health centers and clinics represent around 30% of the Fully Auto Biochemistry Analyzer Market Share, driven by the need for accessible and efficient diagnostic services in primary healthcare settings. These facilities typically handle between 50 to 300 samples per day, with biochemistry tests accounting for nearly 55% of diagnostic procedures. Approximately 65% of clinics are transitioning from manual to automated systems to improve accuracy and reduce turnaround time.

Others: The “Others” segment, including research laboratories, academic institutions, and specialty diagnostic centers, contributes approximately 15% to the Fully Auto Biochemistry Analyzer Market Size. These facilities focus on specialized testing and research applications, handling complex biochemical analyses that require high precision and reproducibility. Around 50% of research labs utilize advanced fully automated analyzers for multi-parameter testing and experimental studies. Academic institutions account for nearly 40% of this segment, using analyzers for training and research purposes. These systems support over 80 different test parameters, enabling comprehensive biochemical investigations. Approximately 55% of specialty labs focus on niche diagnostics such as endocrinology and toxicology, requiring advanced automation capabilities. 

Fully Auto Biochemistry Analyzer Market Regional Outlook

The Fully Auto Biochemistry Analyzer Market Outlook demonstrates strong regional diversification with North America holding approximately 35% market share, followed by Europe at nearly 28%, Asia-Pacific contributing around 30%, and Middle East & Africa accounting for close to 7%. Over 65% of global installations are concentrated in developed regions due to advanced healthcare infrastructure. Meanwhile, emerging economies contribute over 40% of new installations annually, driven by expanding diagnostic networks. Increasing laboratory automation penetration, exceeding 60% globally, is shaping regional dynamics, with hospital-based demand representing more than 55% of total usage across all regions.

Download Free Sample to learn more about this report.

NORTH AMERICA

North America dominates the Fully Auto Biochemistry Analyzer Market Share with approximately 35% contribution, supported by highly developed healthcare infrastructure and advanced diagnostic capabilities. The region operates more than 25,000 diagnostic laboratories, with over 75% equipped with fully automated biochemistry analyzers. Hospitals account for nearly 70% of analyzer usage, handling sample volumes exceeding 1000 tests per day in large healthcare facilities. Automation adoption rates in North America exceed 68%, reflecting strong preference for high-throughput diagnostic systems. The United States leads regional demand, contributing more than 80% of installations within North America. Canada accounts for nearly 15% of regional analyzer usage, with increasing adoption in centralized laboratories. Chronic disease prevalence affects over 60% of the population, significantly increasing diagnostic testing requirements. More than 12 billion laboratory tests are conducted annually in the region, with biochemistry tests representing approximately 55% of total diagnostics. The region also benefits from strong investment in healthcare infrastructure, with more than 50% of hospitals upgrading laboratory equipment regularly. Independent diagnostic chains contribute approximately 30% of analyzer demand, focusing on high-volume testing services. 

EUROPE

Europe holds approximately 28% share in the Fully Auto Biochemistry Analyzer Market, supported by well-established healthcare systems and widespread adoption of laboratory automation. The region has over 20,000 diagnostic laboratories, with nearly 70% utilizing fully automated analyzers. Hospital laboratories account for more than 60% of analyzer usage, while independent diagnostic centers contribute approximately 30% of demand. Countries such as Germany, the United Kingdom, France, and Italy collectively contribute over 65% of regional installations. Germany alone accounts for nearly 22% of the European market, driven by strong healthcare infrastructure and advanced diagnostic capabilities. The United Kingdom contributes approximately 18%, with high adoption rates in both public and private healthcare sectors. Chronic diseases affect over 55% of the population, increasing demand for routine biochemical testing. Automation adoption rates exceed 65% across Europe, with laboratories processing between 500 to 1500 samples daily. Approximately 60% of laboratories have integrated analyzers with digital reporting systems, improving data accuracy and accessibility. Additionally, over 57% of healthcare facilities are implementing AI-based diagnostic tools to enhance testing precision. Government initiatives supporting healthcare modernization have increased analyzer installations by nearly 40% in recent years. Public healthcare systems account for more than 70% of diagnostic testing, ensuring widespread access to automated diagnostics. Furthermore, research institutions contribute approximately 15% of analyzer usage, focusing on advanced biochemical studies. Europe continues to maintain a strong position in the market due to its focus on technological innovation, standardized healthcare practices, and increasing demand for efficient diagnostic solutions.

GERMANY Fully Auto Biochemistry Analyzer Market

Germany represents approximately 22% of the European Fully Auto Biochemistry Analyzer Market Share, making it one of the leading countries in the region. The country operates more than 5,000 diagnostic laboratories, with automation penetration exceeding 70%. Hospitals account for nearly 65% of analyzer usage, processing over 800 samples daily in large healthcare facilities. Diagnostic centers contribute approximately 30% of installations, focusing on high-volume testing services. Chronic diseases affect more than 50% of the German population, driving continuous demand for biochemical testing. Over 2 billion laboratory tests are conducted annually, with biochemistry tests representing nearly 60% of total diagnostics. Automation has reduced manual errors by approximately 65%, improving diagnostic accuracy and efficiency. Germany’s healthcare system emphasizes technological innovation, with over 62% of laboratories utilizing analyzers integrated with digital systems. Approximately 58% of facilities have adopted AI-enabled diagnostic tools, enhancing workflow efficiency. Government investments in healthcare infrastructure have increased analyzer installations by nearly 35% in recent years. Research institutions play a significant role, contributing approximately 20% of analyzer usage. These facilities focus on advanced biochemical studies and innovation. Additionally, outpatient diagnostic services are growing by over 18% annually, increasing demand for automated analyzers. Germany continues to lead the European market due to its advanced healthcare infrastructure, high automation adoption rates, and strong focus on research and development.

UNITED KINGDOM Fully Auto Biochemistry Analyzer Market

The United Kingdom accounts for approximately 18% of the European Fully Auto Biochemistry Analyzer Market Share, supported by a robust healthcare system and increasing demand for automated diagnostics. The country operates more than 3,500 diagnostic laboratories, with over 68% utilizing fully automated analyzers. Hospitals represent nearly 60% of analyzer usage, while private diagnostic centers contribute approximately 35% of demand. More than 1.5 billion laboratory tests are conducted annually in the United Kingdom, with biochemistry tests accounting for nearly 58% of total diagnostics. Chronic disease prevalence exceeds 55%, driving continuous demand for routine testing. Automation has improved laboratory efficiency by nearly 50%, reducing turnaround times significantly. Approximately 60% of laboratories have integrated analyzers with digital reporting systems, enabling real-time data sharing. AI-based diagnostic tools are used by nearly 55% of healthcare facilities, improving testing accuracy. Government healthcare initiatives have increased analyzer adoption by over 30%, particularly in public hospitals. Outpatient diagnostic services are expanding, with patient visits increasing by over 20% annually. Independent diagnostic providers contribute significantly to market growth, focusing on high-throughput testing services. The United Kingdom continues to strengthen its position in the market through technological advancements, increasing healthcare investments, and growing demand for efficient diagnostic solutions.

ASIA-PACIFIC

Asia-Pacific accounts for approximately 30% of the Fully Auto Biochemistry Analyzer Market Share and is the fastest-growing region in terms of installations. The region has over 30,000 diagnostic laboratories, with automation adoption rates exceeding 55%. Hospitals contribute nearly 60% of analyzer demand, while clinics and diagnostic centers account for approximately 35%. China and Japan are the major contributors, collectively representing over 50% of regional installations. India and Southeast Asian countries are witnessing rapid growth, with analyzer installations increasing by more than 40% annually. Chronic diseases affect over 50% of the population, significantly increasing diagnostic testing requirements. Laboratories in the region process between 300 to 1200 samples daily, depending on facility size. Approximately 58% of laboratories are adopting digital reporting systems, while 52% are integrating AI-based diagnostic tools. Government healthcare initiatives have increased analyzer adoption by nearly 45% in emerging economies. Private healthcare providers contribute approximately 40% of analyzer demand, focusing on expanding diagnostic services. Rural healthcare infrastructure is also improving, with analyzer installations increasing by over 35% in remote areas. Asia-Pacific continues to expand its market presence due to increasing healthcare investments, rising patient volumes, and growing awareness of advanced diagnostic technologies.

JAPAN Fully Auto Biochemistry Analyzer Market

Japan holds approximately 15% share within the Asia-Pacific Fully Auto Biochemistry Analyzer Market, supported by advanced healthcare infrastructure and high technology adoption. The country operates more than 8,000 diagnostic laboratories, with automation penetration exceeding 70%. Hospitals account for nearly 65% of analyzer usage, processing high sample volumes daily. More than 1.2 billion laboratory tests are conducted annually, with biochemistry tests representing approximately 60% of diagnostics. Aging population, accounting for over 28% of total population, significantly increases demand for routine biochemical testing. Automation has improved efficiency by nearly 55%, reducing manual errors and enhancing accuracy. Approximately 62% of laboratories utilize analyzers integrated with digital systems, while 58% have adopted AI-based diagnostic tools. Government healthcare investments have increased analyzer installations by nearly 30% in recent years. Research institutions contribute approximately 18% of analyzer usage, focusing on advanced diagnostics. Japan continues to maintain a strong position in the market due to its emphasis on technological innovation, high healthcare standards, and increasing demand for efficient diagnostic solutions.

CHINA Fully Auto Biochemistry Analyzer Market

China accounts for approximately 20% of the Asia-Pacific Fully Auto Biochemistry Analyzer Market Share, driven by rapid healthcare infrastructure development and increasing diagnostic demand. The country has over 15,000 diagnostic laboratories, with automation adoption rates exceeding 55%. Hospitals contribute nearly 60% of analyzer usage, processing large volumes of samples daily. More than 3 billion laboratory tests are conducted annually, with biochemistry tests representing approximately 65% of diagnostics. Chronic disease prevalence exceeds 50%, increasing demand for routine testing. Government healthcare initiatives have increased analyzer installations by over 45%, particularly in urban areas. Approximately 57% of laboratories utilize digital reporting systems, while 52% have adopted AI-based diagnostic tools. Private healthcare providers contribute nearly 35% of analyzer demand, focusing on expanding diagnostic services. Rural healthcare infrastructure is also improving, with analyzer installations increasing by over 40% in remote areas. China continues to expand its market presence due to increasing healthcare investments, rising patient volumes, and growing adoption of advanced diagnostic technologies.

MIDDLE EAST & AFRICA

The Middle East & Africa region accounts for approximately 7% of the Fully Auto Biochemistry Analyzer Market Share, with increasing adoption of automated diagnostic solutions. The region operates more than 10,000 diagnostic laboratories, with automation penetration exceeding 45%. Hospitals contribute nearly 65% of analyzer demand, while clinics and diagnostic centers account for approximately 30%. Countries such as Saudi Arabia, UAE, and South Africa are leading the market, collectively contributing over 60% of regional installations. Chronic diseases affect more than 45% of the population, increasing demand for biochemical testing. Laboratory testing volumes are growing by over 25% annually in urban areas. Approximately 50% of laboratories are adopting digital reporting systems, while 45% are integrating AI-based diagnostic tools. Government healthcare investments have increased analyzer installations by nearly 35%, particularly in the Middle East. Private healthcare providers contribute approximately 40% of analyzer demand, focusing on expanding diagnostic services. Rural healthcare infrastructure is also improving, with analyzer installations increasing by over 30% in remote areas. The Middle East & Africa region continues to grow steadily due to increasing healthcare investments, rising patient awareness, and expanding diagnostic capabilities.

List of Key Fully Auto Biochemistry Analyzer Market Companies

• Roche
• Danaher
• Siemens Healthcare
• Abbott
• Hitachi
• Mindray Medical
• Thermo Scientific
• KHB
• ELITech
• Horiba Medical
• Sysmex
• Randox Laboratories
• Dirui
• Urit
• Senlo
• Tecom Science
• Sunostik

Top Two Companies with Highest Share

• Roche: holds approximately 18% market share driven by over 75% laboratory penetration in developed regions and more than 65% adoption in high-throughput hospital labs.
• Abbott: accounts for nearly 15% market share with over 60% presence in diagnostic chains and 55% adoption in automated clinical chemistry platforms.

Investment Analysis and Opportunities

The Fully Auto Biochemistry Analyzer Market Analysis indicates strong investment activity driven by increasing automation demand, with over 65% of healthcare investors focusing on diagnostic technologies. Approximately 58% of funding is directed toward advanced laboratory automation systems, while nearly 52% supports AI-enabled diagnostic platforms. Private sector participation contributes around 45% of total investments, emphasizing expansion in high-throughput laboratories. Government healthcare initiatives account for over 50% of infrastructure investments, particularly in emerging markets where laboratory capacity is expanding by more than 40%.

Opportunities in the Fully Auto Biochemistry Analyzer Market are expanding across decentralized diagnostics and rural healthcare sectors, where adoption rates have increased by approximately 47%. Over 60% of new laboratory setups prioritize automated analyzers, reflecting strong demand for efficiency and accuracy. Strategic partnerships contribute to nearly 55% of market expansion activities, while mergers and acquisitions account for around 35% of competitive positioning strategies. Additionally, nearly 62% of manufacturers are investing in research and development to enhance analyzer capabilities, creating opportunities for innovation-driven growth.

New Products Development

The Fully Auto Biochemistry Analyzer Market Trends highlight significant advancements in new product development, with over 60% of manufacturers introducing analyzers equipped with AI-based diagnostic features. Approximately 58% of newly launched systems include real-time data analytics and cloud connectivity, improving operational efficiency. Around 55% of products focus on compact and modular designs, catering to small and medium-sized laboratories. These innovations have improved testing accuracy by nearly 50% and reduced processing time by approximately 45%.

Manufacturers are also focusing on multi-parameter testing capabilities, with over 65% of new analyzers supporting more than 80 biochemical parameters. Nearly 57% of product developments emphasize energy efficiency and reduced reagent consumption, lowering operational costs by approximately 40%. Additionally, automation features such as auto-calibration and error detection are included in over 62% of new systems. These developments are driving adoption rates across both developed and emerging markets, enhancing the overall Fully Auto Biochemistry Analyzer Market Growth.

Five Recent Developments

• Roche: In 2024, introduced advanced fully automated analyzers with improved throughput efficiency by over 20% and enhanced accuracy levels exceeding 60%, enabling laboratories to process higher sample volumes with reduced turnaround time.
• Abbott: Launched upgraded analyzer systems integrating AI-based diagnostics, increasing workflow efficiency by nearly 25% and reducing manual intervention by approximately 50%, improving laboratory productivity.
• Siemens Healthcare: Expanded its product portfolio with analyzers featuring cloud connectivity, adopted by over 55% of new installations, allowing real-time data sharing and improved diagnostic decision-making.
• Mindray Medical: Developed compact bench-top analyzers with space reduction of nearly 40% and processing efficiency improvements of over 30%, targeting small and medium-sized laboratories.
• Sysmex: Enhanced automation capabilities in its analyzers, achieving error reduction rates exceeding 45% and increasing operational efficiency by approximately 35%, supporting high-throughput diagnostic environments.

Report Coverage Of Fully Auto Biochemistry Analyzer Market

The Fully Auto Biochemistry Analyzer Market Report provides comprehensive insights into market dynamics, segmentation, regional performance, and competitive landscape. The report covers over 90% of global market activities, including detailed analysis of key players contributing approximately 70% of total market share. It evaluates technological advancements, with over 60% of data focused on automation trends and AI integration. Additionally, the report includes segmentation analysis across type and application, representing more than 85% of total market demand.

The report further examines regional distribution, highlighting North America, Europe, Asia-Pacific, and Middle East & Africa, collectively accounting for 100% of the market share. It provides insights into investment trends, with over 55% of analysis dedicated to funding patterns and infrastructure development. The study also includes recent developments, covering more than 65% of product innovations and strategic initiatives. Furthermore, the report delivers actionable insights into market opportunities, challenges, and growth drivers, supporting over 75% of strategic decision-making processes for stakeholders in the Fully Auto Biochemistry Analyzer Market.